Related Experiment Videos
[Current chemotherapy in urinary tract infection]
1Urologische Klinik, Ludwig-Maximilians-Universität München.
Der Urologe. Ausg. A
|January 1, 1993
Summary
Choosing the right antibiotic for urinary tract infections (UTIs) depends on local resistance patterns and patient risk factors. Effective treatment requires proper clinical classification and tailored antibiotic selection for optimal outcomes.
Area of Science:
- Pharmacology
- Infectious Diseases
- Urology
Context:
- Urinary tract infections (UTIs) present a significant challenge due to the availability of numerous chemotherapeutics.
- Selecting the most suitable antimicrobial agent requires careful consideration of various factors.
Purpose:
- To guide the selection of appropriate antimicrobial agents for treating urinary tract infections (UTIs).
- To outline treatment strategies based on UTI classification, severity, and patient-specific risk factors.
Summary:
- First-line oral treatments for UTIs include benzylpyrimidine/sulphonamide combinations, amino-penicillins, fluoroquinolones, and cephalosporins.
- Intravenous options for severe infections include these agents, plus aminoglycosides or imipenem/cilastin.
- Knowledge of local resistance patterns is crucial for empirical treatment decisions.
- Special populations (children, pregnant women, immunocompromised, renal insufficiency) require particular attention.
- Acute uncomplicated cystitis is treated with oral antibiotics (single-shot or 3-day).
- Acute uncomplicated pyelonephritis requires 7-day therapy or 3 days post-fever resolution.
- Complicated UTIs or cases with impaired enteral absorption necessitate 10-14 days of intravenous therapy.
Impact:
- Informed antibiotic selection can improve treatment efficacy and reduce antimicrobial resistance.
- Standardized treatment guidelines enhance patient care and clinical decision-making for UTIs.
- Understanding risk factors and local resistance patterns optimizes therapeutic outcomes in diverse patient groups.